Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results confirm the associations of SNCA, LRRK2, BST1, and PARK16 with PD susceptibility and fail to show significant associations of AD genome-wide association study (GWAS) top hits with PD susceptibility in a Korean population.
|
23820587 |
2013 |
Movement Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Our findings suggest that additional studies of PARK16-18 are necessary to establish the role of these loci in modifying risk for Parkinson's disease in European-derived populations.© 2011 Movement Disorder Society.
|
21425343 |
2011 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Here we show that the consequences of variants at 2 such loci, PARK16 and LRRK2, are highly interrelated, both in terms of their broad impacts on human brain transcriptomes of unaffected carriers, and in terms of their associations with PD risk.
|
23395371 |
2013 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The majority of studies have confirmed the association of the previously identified genetic risk factors, SNCA and MAPT, and two studies have identified three new PD susceptibility loci/genes (PARK16, BST1 and HLA-DRB5).
|
21812969 |
2011 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data does not support a strong direct interaction between LRRK2 and PARK16 variants; however, given the role of retromer and lysosomal pathways in PD, further studies are warranted.
|
27814993 |
2017 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In a logistic regression analysis with SNPs coded under an additive model, there was no significant genetic interaction between the LRRK2 and the PARK16 locus gene RAB7L1 in PD risk.
|
23820587 |
2013 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We replicated the effect of a new locus detected in the Japanese cohort (PARK16, rs823128, OR = 0.66, P = 7.29 x 10(-8)) and provide supporting evidence that common variation around LRRK2 modulates risk for PD (rs1491923, OR = 1.14, P = 1.55 x 10(-5)).
|
19915575 |
2009 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data provide a novel insight and further information regarding PARK16-18 loci in PD susceptibility.
|
24373818 |
2014 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our findings suggest that additional studies of PARK16-18 are necessary to establish the role of these loci in modifying risk for Parkinson's disease in European-derived populations.© 2011 Movement Disorder Society.
|
21425343 |
2011 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Finally, ADORA1 is located within the Parkinson's disease locus PARK16, which has been identified in several populations.
|
27134041 |
2016 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We showed that multiple SNPs at LRRK2 and SNCA increase risk of PD, while PARK16 SNPs are associated with a lower risk of PD in China.
|
21268244 |
2011 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data demonstrate that specific SNP variations and haplotypes in the PARK16 locus are associated with reduced risk for PD in Ashkenazim.
|
22232350 |
2012 |
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
CTD_human |
By comparing results of a GWAS performed on individuals of European ancestry, we identified PARK16, SNCA and LRRK2 as shared risk loci for PD and BST1 and MAPT as loci showing population differences.
|
19915576 |
2009 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Association between PARK16 gene polymorphisms and susceptibility of Parkinson's disease in a Chinese population.
|
25966061 |
2015 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, gene SLC41A1 located in the novel PD locus PARK16 has recently been identified as being a Na⁺/Mg²⁺ exchanger (NME, Mg²⁺ efflux system), a key component of cellular magnesium homeostasis.
|
23976986 |
2013 |
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
CTD_human |
We replicated the effect of a new locus detected in the Japanese cohort (PARK16, rs823128, OR = 0.66, P = 7.29 x 10(-8)) and provide supporting evidence that common variation around LRRK2 modulates risk for PD (rs1491923, OR = 1.14, P = 1.55 x 10(-5)).
|
19915575 |
2009 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The PARK16 locus was reported to alter the risk of Parkinson's disease (PD) in genomewide association studies in Japanese and Caucasians.
|
25758099 |
2015 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In a 9-year longitudinal study, we demonstrated that PD PARK16 variant carriers exhibited greater motor progression after 5 years of disease compared with non-carriers, suggesting that GWAS-linked gene variants may influence disease progression over time.
|
30814270 |
2019 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Using a dataset of post-mortem brain samples assayed for gene expression (n = 399) and methylation (n = 292), we identified methylation and expression changes associated with PD risk variants in PARK16/1q32, GPNMB/7p15, and STX1B/16p11 loci, hence suggesting potential molecular mechanisms and candidate genes at these risk loci.
|
21738488 |
2011 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
An association between the PARK16 locus and Parkinson's disease in a cohort from eastern China.
|
21840748 |
2011 |
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
In the present study, we aimed to explore the contribution of PARK16 variability to PD risk in a Scandinavian population.
|
25855069 |
2015 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
PARK16 was identified as a risk factor for Parkinson's disease in a Japanese cohort; however, subsequent studies in the other populations including the Chinese, European, Caucasian, and Chilean have shown a protective role instead.
|
27174169 |
2016 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The PARK16 SNPs rs823128, rs947211, and rs823156 and the CAAAC, TGAGA, and CAGAC haplotypes may be significantly associated with sporadic PD in Japan.
|
26944116 |
2016 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Within its limitations, this meta-analysis demonstrated that the rs823128 variants(G allele, GA and GG genotype)in PARK16 might be a potential protective factor for PD.
|
29191693 |
2018 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Further analysis is required to determine the role of genes within the PARK16 locus in development of PD.
|
21812739 |
2011 |